電気泳動試薬市場レポート：動向、予測、競合分析 (2031年まで)

世界の電気泳動試薬市場の将来は、ライフサイエンス・バイオテクノロジー、臨床診断、製薬・バイオ医薬品、学術・研究機関市場の機会で有望視されています。世界の電気泳動試薬市場は、2025年から2031年にかけてCAGR 5.2％で成長すると予想されます。この市場の主な促進要因は、医療・製薬セクターの急成長と個別化医療への嗜好の高まりです。

• Lucintel社の予測によると、種類別では、遺伝学、ゲノミクス、分子生物学研究に広く使用されているゲルが予測期間中に最も高い成長を遂げる見込みです。
• 最終用途別では、ライフサイエンス・バイオテクノロジーが最も高い成長が見込まれています。この分野では、DNAシークエンシング、ジェノタイピング、タンパク質分析、バイオ医薬品の品質管理など、さまざまな技術で電気泳動試薬の使用が増加しているためです。
• 地域別では、ゲノム研究プロジェクトの増加、生体分子の正確で信頼性の高い分析に対するニーズの高まり、主要企業の存在などから、北米が予測期間中に最も高い成長を示すと予想されます。

電気泳動試薬市場の戦略的成長機会

電気泳動試薬市場は、主要用途における戦略的成長分野によって著しい成長を遂げようとしています。これらの機会は、ゲノミクス、プロテオミクス、臨床診断、創薬において電気泳動の利用が増加していることから生じています。このような可能性を活用するためには、企業は市場での存在感を高め、特定の目的に合わせて設計された高度な電気泳動試薬に対する需要の高まりに応える必要があります。

• ゲノム調査：電気泳動試薬市場のこの分野には大きな成長の見込みがあり、関心を持つ企業が継続的に参入することが可能です。個別化医療や遺伝子研究の動向の高まりにより、DNAとRNAを効果的に分離する高感度で特異的な試薬の需要が高まっています。ハイスループットなゲノム解析には、複雑なゲノム解析を実行できる特殊な試薬が必要です。
• 臨床診断：臨床診断は、電気泳動試薬の主な応用分野の一つであり、その開発が期待されています。慢性疾患の罹患率の増加と精密な診断ツールの必要性が、臨床検査室における電気泳動技術の採用を促進しています。これに対応するため、特に遺伝性疾患の同定やがん診断のケースにおいて、信頼性が高く再現性のある結果を提供できるような試薬の開発が必要です。
• プロテオミクス調査：プロテオミクス研究は、大きな成長の可能性を秘めたもう一つの分野であり、大規模なタンパク質の研究が含まれます。電気泳動分析は、プロテオミクスにおけるタンパク質の発現、構造、機能を科学的に調べるのに役立ちます。プロテオミクス研究はますます複雑化しており、複雑なタンパク質混合物の分離と分析を容易にする、より高度な試薬の需要が高まっています。
• 創薬と開発：電気泳動技術は、潜在的な医薬品候補のスクリーニングや分析に、創薬・開発プロセスで多用されています。製薬会社は研究開発への投資を続けており、これらのプロセスで使用できる電気泳動試薬への要求が高まっています。これは、創薬プログラムの特定のニーズに合わせた試薬を開発する企業にとって、戦略的な成長機会となります。
• 学術・研究機関：科学研究と教育に重点が置かれているため、学術・研究機関は電気泳動試薬の主要市場となっています。研究プロジェクトの増加と高品質の教育用試薬の必要性が相まって、学術研究機関が必要とする特殊な製品に新たな市場開拓の機会が生まれています。

このような主要用途にわたる戦略的成長機会が、電気泳動試薬市場を前進させています。これらの分野に注力することで、企業は高度な試薬に対する需要の増加を活用し、製品ポートフォリオを強化し、市場での競合優位性を確保することができます。

電気泳動試薬市場の促進要因・課題

電気泳動試薬業界は、長期的な成長軌道を形成する様々な促進要因と課題を経験しています。技術の進歩、経済的要因、規制上の懸念は、この業界の行く末を決定する重要な役割を果たしています。これらの促進要因と課題を理解することは、業界関係者が競合情勢をナビゲートし、新たな機会を捉えるために不可欠です。

電気泳動試薬市場を牽引する要因は以下の通りである：

1.技術進歩：電気泳動技術とその反応剤に関する技術の進歩は、より多くの試薬の必要性に大きく寄与しています。電気泳動は、その分解能、感度、自動化適合性の向上により、様々な用途で採用されており、電気泳動の効率と精度を向上させた次世代の高度な試薬の開発につながりました。

2.ゲノミクスとプロテオミクスにおける需要の高まり：電気泳動試薬の需要は、ゲノミクスとプロテオミクスの研究への集中の高まりに牽引されています。遺伝子解析もタンパク質解析も、電気泳動なしでは行えないのは、非常に精密な分離技術があってこそです。個別化医療とバイオマーカー探索の台頭は、この需要をさらに増幅させています。

3.臨床応用の拡大：臨床診断における電気泳動の利用拡大は、市場の重要な促進要因です。遺伝性疾患やがんなどの診断にこの方法を採用する必要性が高まっており、その結果、人の健康に影響を与えるさまざまな問題に関連する異なるタンパク質を区別するのに役立つため、需要が増加しています。

4.研究資金の増加：政府、非政府組織、財団などがバイオテクノロジー、製薬、生命科学などの分野の科学研究に割り当てる資金が増加していることが、世界の電気泳動試薬市場の成長率を高めています。このような開発に対する政府筋の民間セクター、あるいは営利団体からの財政支援の増加は、このような製品に対する需要レベルを高め、それ別このセグメントの成長を後押ししています。

5.戦略的提携と合併：戦略的提携、パートナーシップ、合併などにより、この業界で事業を展開する企業は、イノベーションを活用することで、自社製品の市場を広く広げることができます。これにより、企業は知的資本リソースをプールすることができ、ライバルに対して競合優位に立つ新商品を迅速に生産することができます。

電気泳動試薬市場における課題は以下の通りである：

1.高価な試薬・装置：電気泳動試薬と装置のコストが高いことが市場の成長を妨げています。小規模の研究所や研究機関では、特殊な試薬や高度なシステムを購入できない可能性があり、コストに敏感な地域での市場拡大が制限されます。

2.厳しい規制：特に臨床応用の場合、電気泳動試薬市場には厳しい規制が適用されます。新製品を導入しようとする企業や市場参入を目指す中小企業にとっては、時間とコストのかかる作業となる可能性があります。

3.先端技術へのアクセスの難しさ：新興国市場におけるアクセス不足は、高度な電気泳動技術市場が直面している問題です。電気泳動技術の利用は、インフラ、技術的ノウハウ、資金などの不足のために遅々として進まないことがあり、そのためこの市場の成長を妨げています。

電流分散液分野の成長と発展は、技術の進歩や実験需要の増加など、これまで述べてきた課題と原動力の両方によって導かれるものですが、これらの要因は、高価格や規制の障害など、いくつかのハードルがあるにもかかわらず、ディーラーが継続性を確保しながらダイナミックな市場状況の中で競争力を維持できるよう、新たな機会を活用することを求めています。

目次

第1章 エグゼクティブサマリー

第2章 世界の電気泳動試薬市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の電気泳動試薬市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の電気泳動試薬市場：種類別
  • ゲル
  • バッファ
  • 染料
  • マーカー・ラダー
• 世界の電気泳動試薬市場：技術別
  • ゲル電気泳動
  • キャピラリー電気泳動
• 世界の電気泳動試薬市場：最終用途別
  • ライフサイエンス・バイオテクノロジー
  • 臨床診断
  • 製薬・バイオ医薬品
  • 学術研究機関
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の電気泳動試薬市場：地域別
• 北米の電気泳動試薬市場
• 欧州の電気泳動試薬市場
• アジア太平洋の電気泳動試薬市場
• その他地域の電気泳動試薬市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の電気泳動試薬市場の成長機会：種類別
  • 世界の電気泳動試薬市場の成長機会：技術別
  • 世界の電気泳動試薬市場の成長機会：最終用途別
  • 世界の電気泳動試薬市場の成長機会：地域別
• 世界の電気泳動試薬市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の電気泳動試薬市場の生産能力拡大
  • 世界の電気泳動試薬市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Agilent Technologies
• GE Healthcare
• Sigma-Aldrich
• Lonza
• Promega
• Takara Bio
• QIAGEN

The future of the global electrophoresis reagent market looks promising with opportunities in the life science & biotechnology, clinical diagnostic, pharmaceutical & biopharmaceutical, and academic & research institution markets. The global electrophoresis reagent market is expected to grow with a CAGR of 5.2% from 2025 to 2031. The major drivers for this market are swift growth in the healthcare and pharmaceutical sectors and an escalating preference for personalized medicine.

• Lucintel forecasts that, within the type category, gel is expected to witness the highest growth over the forecast period due to its extensive employment in genetics, genomics, and molecular biology research.
• Within the end-use category, life science & biotechnology are expected to witness the highest growth due to the increasing usage of electrophoresis reagents in this sector for various techniques, such as DNA sequencing, genotyping, protein analysis, and quality control of biopharmaceutical products.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the rising number of genomic research projects, growing need for accurate & reliable analysis of biomolecules, and the presence of key players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Electrophoresis Reagent Market

Over time, technological advancements, increased research undertakings, and changing industry demands have been responsible for transformative changes within the electrophoresis reagent market. Several trends are emerging as it undergoes further expansion, reshaping its landscape. Hence, these trends affect how developers apply or integrate themselves into various applications, thereby creating new opportunities and threats from the perspectives of sector players.

• Automation Shift: The trend toward automation in laboratories has drastically altered the electrophoresis reagent market. Automated electrophoresis systems are increasingly being used because of their ability to deliver highly accurate, high-throughput results with reduced manual intervention. This shift is pushing for reagents that are compatible with automated platforms, which compels manufacturers to innovate and develop products that satisfy this changing need.
• Emphasis on Sustainability: Electrophoresis reagent production and use are now driven by sustainability concerns. The demand for green reagents that reduce environmental impact is increasing, such as those made of biodegradable components or having lower toxicity levels. Thus, businesses have been investing in green chemistry and sustainable production processes, not only to meet regulatory requirements but also to attract environmentally conscious customers and institutions.
• Genomics and Personalized Medicine: The increased focus on personalized medicine and genomics has created a demand for electrophoresis reagents designed specifically for individual genetic analyses. With the rise in personalized treatments, there is a need for highly accurate, reliable reagents that can support detailed genetic profiling as well as biomarker discovery. This trend is driving specialized reagents aimed at improving the accuracy and sensitivity of genomic studies.
• AI Integration with Data Analytics: The integration of artificial intelligence (AI) and data analytics into electrophoresis processes has changed the market forever. AI-driven platforms allow for more precise and faster analysis of electrophoresis results, thereby reducing human error while increasing efficiency. This development encourages the formulation of reagents optimized for use in AI-based systems, leading researchers toward achieving more reproducible outcomes based on improved confidence.
• Expansion in Clinical Applications: One important trend within the market is the expanded use of electrophoresis applications in clinical diagnostics. Electrophoresis is increasingly being used to diagnose various conditions, including cancers and genetic disorders. This growing adoption by clinicians fuels demand for high sensitivity, specificity, and consistency, which are critical for accurate diagnostic results. Recent regulatory changes also support the use of electrophoresis for clinical purposes.

Innovation, sustainability, and broadened applications are making these emerging trends reshape the electrophoresis reagent market. These will influence new product development as the market advances, improve research capabilities, and create opportunities in clinical and diagnostic areas.

Recent Developments in the Electrophoresis Reagent Market

The electrophoresis reagents market has seen remarkable developments due to growing research needs, technological advancements, and changing market dynamics. This has led to changes in the way reagents are manufactured, distributed, and applied for different uses, particularly genomics, clinical diagnostics, and drug discovery. Below are five key developments that will shape the future of electrophoresis reagent market.

• Innovations in Reagent Formulations: Recent reagent formulations innovations have improved the performance qualities of electrophoresis techniques. Companies have been able to develop reagents that are more suitable for advanced electrophoresis systems since they offer better resolution, sensitivity, or compatibility features among others. Such innovations allow much more precise separation as well as analysis of biomolecules which is important for both research and diagnostic applications. These formulations have therefore found wide application within academic institutions and commercial laboratories across various fields at a much faster pace than expected.
• Seeking Friendly Collaborations and Partnerships: Collaborations among companies in the electrophoresis reagent market are becoming more strategic in nature. These partnerships aim to combine knowledge for new product development, expanding into new markets, and improving technological capabilities. Such collaborations fuel innovation and allow for the production of advanced reagents for the needs of the worldwide scientific community which is on a steady increase.
• Expansion of Manufacturing Capacities: Manufacturers have also been expanding their facilities as they strive to meet growing electrophoresis reagents demand. This trend is particularly notable in the Asia-Pacific region because biotechnology and pharmaceutical research are undergoing rapid growth that besides drives demand for Reagents. Through increasing production capacities, firms can be able to deliver high-quality reagents at affordable rates hence strengthening their competitive edge.
• Adoption of Digital Tools for Reagent Development: Digital tools and software have revolutionized reagent user experience across all industries including marketing automation platforms such as HubSpot CRM and Salesforce CRM. They are using these tools to optimize formulation procedures, improve quality control standards, and shorten product development cycles. By embracing digital technology, businesses have started understanding customer expectations better than ever before leading to more specific and effective solutions for reagents.
• Regulatory Approvals and Compliance: Regulatory approvals changes have had an impact on the electrophoresis reagent market recently. Companies are increasingly focusing on ensuring that their products comply with strict regulatory frameworks especially when targeting clinical applications. In some locations, getting regulatory approval may not only validate a company's offering but also provide access to larger markets where healthcare regulations may be stringent. Thus, there is a need for manufacturers to pay attention to compliance issues by improving the safety features of their products through enhanced manufacturing practices.

These key developments drive forward the electrophoretic markers; contribute towards fostering innovations; expand capabilities and ensure the observance of rules and regulations. Such developments are likely to play a significant part in determining the future direction of this market as it continues to expand.

Strategic Growth Opportunities for Electrophoresis Reagent Market

The electrophoresis reagent market is set for remarkable growth due to strategic growth areas within key applications. These opportunities emanate from the increasing use of electrophoresis across genomics, proteomics, clinical diagnostics, and drug discovery. To take advantage of these possibilities, enterprises must improve their presence on the market and meet the growing demand for advanced electrophoresis reagents designed for specific purposes.

• Genomic Research: There are significant prospects for growth in this sector of the electrophoresis reagent market which can be continually tapped into by interested parties. The rising trend towards personalized medicine, as well as genetic research, has increased demand for highly sensitive and specific reagents that separate DNA and RNA effectively. High-throughput genomic analyses call for specialized reagents that can perform complex genomic analysis; hence, fostering innovation and driving progress in this area.
• Clinical Diagnostics: Clinical diagnostics is one of the key application areas of electrophoresis reagents with a promising perspective on its development. The increasing incidence rate of chronic diseases along with the need for precise diagnostic tools have facilitated the adoption of electrophoresis techniques at clinical laboratories. In response, there should be development of such reagents that could offer reliable and reproducible results especially when dealing with genetic disorders identification or cancer diagnosis cases.
• Proteomics Research: Proteomic research is another field that has great growth potential and involves the study of proteins on a large scale. Electrophoresis analysis helps to examine protein expression, structure, and function in proteomics scientifically. The ever-increasing complexity of proteomics research is boosting the demand for more advanced reagents that can facilitate the separation and analysis of complex protein mixtures thereby providing an opportunity for market expansion.
• Drug Discovery and Development: Electrophoresis techniques are heavily used in drug discovery and development processes for screening and analyzing potential drug candidates. As pharmaceutical companies continue investing in R&D, they are increasingly demanding electrophoresis reagents that can be used in these processes. This presents a strategic growth opportunity for companies to develop reagents tailored to the specific needs of drug discovery programs.
• Academic and Research Institutions: The emphasis on scientific research and education makes academic/research institutions a major market for electrophoresis reagents. Increasing numbers of research projects coupled with the need for high-quality educational reagents create opportunities for specialized products required by academic laboratories to reach out into new markets.

These strategic growth opportunities across key applications are driving the electrophoresis reagent market forward. By focusing on these areas, companies can capitalize on the increasing demand for advanced reagents, enhance their product portfolios, and secure a competitive edge in the market.

Electrophoresis Reagent Market Driver and Challenges

The electrophoretic reagent industry experiences various drivers as well as challenges that shape its growth trajectory over time. Technological advancements, economic factors, regulatory concerns play important roles determining where this industry goes from here. Understanding these drivers and challenges is essential for industry players to navigate through competition landscape as well as capturing emerging opportunities.

The factors responsible for driving the electrophoresis reagent market include:

1. Technological Advancements: The advancements made in technology regarding electrophoresis techniques alongside its reactive agents have significantly contributed to the need for more reagents. Electrophoresis is being adopted across various applications due to its improved resolution, sensitivity, and automation compatibility which has led to the development of the next generation of advanced reagents that have enhanced efficiency and accuracy in electrophoresis.

2. Growing Demand In Genomics And Proteomics: The demand for electrophoresis reagents is driven by the increasing concentration on genomics and proteomics research. It is only through a very precise separation technique, that both genetic and protein analysis alone cannot be done without electrophoresis. The rise of personalized medicine and biomarker discovery further amplifies this demand.

3. Expansion Of Clinical Applications: The expanding use of electrophoresis in clinical diagnostics is a significant driver for the market. There is an increased need for employing this method in diagnosing genetic disorders as well as cancer among other diseases thus increasing its demand since it can help differentiate between different proteins which are linked with different issues affecting human health.

4. Increasing Research Funding: Increasing funds allocated by governments, non-governmental organizations, foundations, etc., to scientific studies in disciplines like biotechnology, pharmaceuticals, life sciences, etc., are enhancing the growth rate of the electrophoretic reagent market worldwide. Increased financial support from government sources private sector or even commercial entities towards these developments increases demand levels for such products thereby boosting growth within this segment.

5. Strategic Collaborations And Mergers: Strategic collaborations, partnerships, mergers among others enable companies operating in this industry to widely spread their products' markets out by tapping into innovation. This allows firms to pool their intellectual capital resources together so that they can quickly produce new goods which would give them a competitive edge against rivals.

Challenges in the electrophoresis reagent market are:

1. Reagents and Equipment are Expensive: Something that holds back growth in the market is the high costs of electrophoresis reagents, and equipment. Smaller laboratories and research institutions may not be able to afford specialized reagents and advanced systems, limiting market expansion in cost-sensitive regions.

2. Stringent Regulatory Obligations: For clinical applications especially, stringent regulations apply to the electrophoresis reagent market. This could be a time-consuming and expensive exercise for companies intending to introduce new products or smaller firms seeking market entry.

3. Advanced Technologies Difficulties Accessing: The shortage of access in developing areas is an issue facing the market of advanced electrophoresis technologies. Use of electrophoresis techniques can be slow due to lack of infrastructure, technical know-how, funding etc., thus hampering growth of this market.

Growth and development in the electric current dispersion liquid sector are guided by both challenges and drives we have discussed above including technological progress as well as increasing demand for experimentation but these factors notwithstanding some hurdles that come with it such as high prices, regulations hindrance among others which calls on dealers to take advantage of emerging opportunities so that they can remain competitive in a dynamic market situation while ensuring continuity.

List of Electrophoresis Reagent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies electrophoresis reagent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the electrophoresis reagent companies profiled in this report include-

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Merck
• Agilent Technologies
• GE Healthcare
• Sigma-Aldrich
• Lonza
• Promega
• Takara Bio
• QIAGEN

Electrophoresis Reagent by Segment

The study includes a forecast for the global electrophoresis reagent market by type, technique, end use, and region.

Electrophoresis Reagent Market by Type [Analysis by Value from 2019 to 2031]:

• Gels
• Buffers
• Stains & Dyes
• Markers & Ladders

Electrophoresis Reagent Market by Technique [Analysis by Value from 2019 to 2031]:

• Gel Electrophoresis
• Capillary Electrophoresis

Electrophoresis Reagent Market by End Use [Analysis by Value from 2019 to 2031]:

• Life Sciences & Biotechnology
• Clinical Diagnostics
• Pharmaceutical & Biopharmaceutical
• Academic & Research Institutions
• Others

Electrophoresis Reagent Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Electrophoresis Reagent Market

Advancements in molecular biology, genetic research, and clinical diagnostics are driving substantial growth in the electrophoresis reagent market on a global scale. This growth is stimulated by rising research and development needs in pharmaceuticals, biotechnology, and academia, among other industries, leading to an increasing demand for electrophoresis techniques. The United States, China, Germany, India, and Japan are some of the key nations contributing to this development, with each country having its unique impact on how the market is changing.

• United States: In the U.S., as funding for genomics research and personalized medicine increases at impressive rates, so does the electrophoresis reagent market. This increase in research activities across academic institutions and biopharmaceutical companies has also created a demand for high-quality reagents. In line with these dynamics, companies have introduced product innovations such as advanced buffer solutions and dyes that support the emerging requirements of researchers, thereby enhancing market expansion further.
• China: Notably, China has become an important player in the electrophoresis reagent market through significant investments in biotechnology and pharmaceutical research. There is increased demand for electrophoresis reagents driven by government emphasis on precision medicine as well as genomic medicine. Local manufacturers are expanding their facilities through global partnerships to boost their presence within this market segment. Thus, favorable policies aimed at enhancing domestic innovation have contributed to this growth.
• Germany: The German electrophoresis reagent market emphasizes quality and innovation. Strong academic-industrial collaboration, plus well-developed scientific infrastructure, fuels the growth of the industry. Henceforth, German firms prefer next-gen reagents with improved sensitivity and accuracy capabilities. Moreover, clinical diagnostic applications have been adopting these techniques, hence Germany's market is expanding.
• India: Rapidly evolving biotech and pharmaceutical sectors underpin India's growing electrophoresis reagent market. Furthermore, the Indian government's promotion of R&D initiatives, coupled with investments from global pharmaceutical companies, is driving market growth. Indian manufacturers have also entered the market with low-cost reagents for domestic and international consumption patterns. An increase in academic research activities has also boosted the demand for electrophoresis reagents in the country.
• Japan: There is stable growth in Japan's electrophoresis reagent market, which is supported by advances in genomic research and government focus on healthcare innovation. The Japanese are designing high-quality materials that respond specifically to researchers' needs. The growing use of electrophoresis in drug discovery and development, along with the increasing prevalence of clinical diagnostics, is driving demand for these types of reagents in Japan. Moreover, this market is fueled by the Japanese government's backing to improve scientific endeavors.

Features of the Global Electrophoresis Reagent Market

Market Size Estimates: Electrophoresis reagent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Electrophoresis reagent market size by type, technique, end use, and region in terms of value ($B).

Regional Analysis: Electrophoresis reagent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, techniques, end uses, and regions for the electrophoresis reagent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the electrophoresis reagent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the electrophoresis reagent market by type (gels, buffers, stains & dyes, and markers & ladders), technique (gel electrophoresis and capillary electrophoresis), end use (life sciences & biotechnology, clinical diagnostics, pharmaceutical & biopharmaceutical, academic & research institutions, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Electrophoresis Reagent Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Electrophoresis Reagent Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Electrophoresis Reagent Market by Type
  • 3.3.1: Gels
  • 3.3.2: Buffers
  • 3.3.3: Stains & Dyes
  • 3.3.4: Markers & Ladders
• 3.4: Global Electrophoresis Reagent Market by Technique
  • 3.4.1: Gel Electrophoresis
  • 3.4.2: Capillary Electrophoresis
• 3.5: Global Electrophoresis Reagent Market by End Use
  • 3.5.1: Life Sciences & Biotechnology
  • 3.5.2: Clinical Diagnostics
  • 3.5.3: Pharmaceutical & Biopharmaceutical
  • 3.5.4: Academic & Research Institutions
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Electrophoresis Reagent Market by Region
• 4.2: North American Electrophoresis Reagent Market
  • 4.2.1: North American Market by Type: Gels, Buffers, Stains & Dyes, and Markers & Ladders
  • 4.2.2: North American Market by End Use: Life Sciences & Biotechnology, Clinical Diagnostics, Pharmaceutical & Biopharmaceutical, Academic & Research Institutions, and Others
• 4.3: European Electrophoresis Reagent Market
  • 4.3.1: European Market by Type: Gels, Buffers, Stains & Dyes, and Markers & Ladders
  • 4.3.2: European Market by End Use: Life Sciences & Biotechnology, Clinical Diagnostics, Pharmaceutical & Biopharmaceutical, Academic & Research Institutions, and Others
• 4.4: APAC Electrophoresis Reagent Market
  • 4.4.1: APAC Market by Type: Gels, Buffers, Stains & Dyes, and Markers & Ladders
  • 4.4.2: APAC Market by End Use: Life Sciences & Biotechnology, Clinical Diagnostics, Pharmaceutical & Biopharmaceutical, Academic & Research Institutions, and Others
• 4.5: ROW Electrophoresis Reagent Market
  • 4.5.1: ROW Market by Type: Gels, Buffers, Stains & Dyes, and Markers & Ladders
  • 4.5.2: ROW Market by End Use: Life Sciences & Biotechnology, Clinical Diagnostics, Pharmaceutical & Biopharmaceutical, Academic & Research Institutions, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Electrophoresis Reagent Market by Type
  • 6.1.2: Growth Opportunities for the Global Electrophoresis Reagent Market by Technique
  • 6.1.3: Growth Opportunities for the Global Electrophoresis Reagent Market by End Use
  • 6.1.4: Growth Opportunities for the Global Electrophoresis Reagent Market by Region
• 6.2: Emerging Trends in the Global Electrophoresis Reagent Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Electrophoresis Reagent Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Electrophoresis Reagent Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Bio-Rad Laboratories
• 7.3: Merck
• 7.4: Agilent Technologies
• 7.5: GE Healthcare
• 7.6: Sigma-Aldrich
• 7.7: Lonza
• 7.8: Promega
• 7.9: Takara Bio
• 7.10: QIAGEN